INTERNATIONAL PATENT: INSIGNIS THERAPEUTICS, INC. FILES APPLICATION FOR "LIQUID EPINEPHRINE PRODRUG FORMULATIONS AND LIQUID EPINEPHRINE FORMULATIONS"

GENEVA, Dec. 31 -- INSIGNIS THERAPEUTICS, INC. (410 Sackett Point RoadBuilding #20North Haven, Connecticut 06473) filed a patent application (PCT/US2025/034581) for "LIQUID EPINEPHRINE PRODRUG FORMULATIONS AND LIQUID EPINEPHRINE FORMULATIONS" on Jun 20, 2025. With publication no. WO/2025/265050, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Mingbao (410 Sackett Point RoadBuilding #20North Haven, Connecticut 06473)

Abstract: The disclosure provides stable liquid non-aqueous epinephrine and epinephrine prodrug for...